DPIIT recognised startup Government of India
Startup India
Cureplus Pharma Private Limited - e-commerce in Bhubaneswar, Odisha, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹91.2 Lakh
▲ 849% YoY
Net profit · FY 2023
₹57,877
Net margin 0.6%
EBITDA · FY 2023
₹9.19 Lakh
EBITDA margin 10.1%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹20 Lakh
Issued & subscribed
Open charges
₹55 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
About Cureplus Pharma Private Limited
Data last updated:
Cureplus Pharma Private Limited is a private limited company based in Bhubaneswar, Odisha, India, recognised as a startup by DPIIT. It operates in the online healthcare product retail segment of the e-commerce sector. It was incorporated on 23 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U51397OR2020PTC035178. Its GSTIN is 21AAJCC1955A1Z9 (Odisha).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Manishankar Panda and Manish Chandra Ram Maurya.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Plot No – 656 Po/Ps – Sahidnagar, Bhubaneswar, Odisha, India – 751007.
As per the financials filed for FY 2023, the company reported a revenue of ₹91.2 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹57,877 (net margin 0.6%) and EBITDA of ₹9.19 Lakh (EBITDA margin 10.1%).
The company is associated with 1 brand: Cureplus Pharma. As per MCA filings, the company has open charges of ₹55 Lakh on record.
Cureplus Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-OD-19-0009200). For more details, the company can be reached via its website curepluspharma.com.
Company Details of Cureplus Pharma Private Limited
CIN U51397OR2020PTC035178
Registration Number 035178
Incorporation Date 23 December 2020
ROC Cuttack
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-OD-19-0009200
Recognitions & Rankings of Cureplus Pharma
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-OD-19-0009200
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No – 656 Po/Ps – Sahidnagar, Bhubaneswar, Odisha, India – 751007
- IndustryE-Commerce, Online Healthcare Product Retail
Comprehensive company report
Cureplus Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Cureplus Pharma Private Limited
Cureplus Pharma operates one associated brand: Cureplus Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Online platform for purchasing medicines and health essentials directly. | curepluspharma.com |
Business Activity of Cureplus Pharma Private Limited
The main business activity of Cureplus Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Cureplus Pharma Private Limited FY 2023 filings available
Cureplus Pharma Private Limited reported revenue of ₹91.2 Lakh (up 849% YoY) for FY 2023.
Revenue · FY 2023
₹91.2 Lakh ▲ 849%
Net profit · FY 2023
₹57,877 margin 0.6%
EBITDA · FY 2023
₹9.19 Lakh margin 10.1%
Compounded Annual Growth Rate (CAGR) of Cureplus Pharma Private Limited
Revenue CAGR growth
1 year
▲ 849%
EBITDA CAGR growth
1 year
▲ 498%
Revenue rose 849% in the latest year. EBITDA rose 498% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Cureplus Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹9.19 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹57,877 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Cureplus Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 10.1% | •••• | •••• |
| Net Profit Margin | 0.6% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Cureplus Pharma are in the company report.
Premium access
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Cureplus Pharma Private Limited
Cureplus Pharma has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manishankar Panda Also directs: Ssaltee IT Private Limited, Manitek Ventures (OPC) Private Limited, Infophy Technologies Private Limited and 2 more | Director | 08 Feb 2023 | 3 Years 8 Months | Current |
| Manish Chandra Ram Maurya Also directs: Mgem Technologies Private Limited | Director | 11 Nov 2025 | 0 Years 11 Months | Current |
Peer Comparison of Cureplus Pharma Private Limited
Cureplus Pharma Private Limited is compared with the companies closest to it by revenue in the Ecommerce and Internet industry (Healthcare Products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Senera Essentials Private Limited | ₹94.15 Lakh (FY 2025) | •••• | •••• | 21.0% | •••• | Indore, Madhya Pradesh, India |
| Ygeiax Sciences Private Limited | ₹92.34 Lakh (FY 2023) | •••• | •••• | 21.0% | •••• | Mumbai, Maharashtra, India |
| Tanmatra Ventures Private Limited | ₹92.13 Lakh (FY 2025) | •••• | •••• | 14.0% | •••• | Kolkata, West Bengal, India |
| Duta Formulations Private Limited | ₹91.76 Lakh (FY 2023) | •••• | •••• | 38.0% | •••• | Bangalore, Karnataka, India |
| Vedsun Natural Herbs Private Limited | ₹91.24 Lakh (FY 2025) | •••• | •••• | 17.0% | •••• | Haridwar, Uttarakhand, India |
| Cureplus Pharma Private Limited this company | ₹91.2 Lakh (FY 2023) | •••• | •••• | 849.0% | •••• | Bhubaneswar, Odisha, India |
| Viamed Lifescience Private Limited | ₹90.8 Lakh (FY 2024) | •••• | •••• | 96.0% | •••• | Pune, Maharashtra, India |
| Good Life Consumer Private Limited | ₹89.5 Lakh (FY 2024) | •••• | •••• | 203318.0% | •••• | Mumbai, Maharashtra, India |
| Audientes India Private Limited | ₹89.41 Lakh (FY 2022) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Taraazi International Private Limited | ₹88.65 Lakh (FY 2022) | •••• | •••• | -47.0% | •••• | New Delhi, Delhi, India |
| Workout Energy Fitness Solutions Private Limited | ₹88.22 Lakh (FY 2024) | •••• | •••• | -4.0% | •••• | Panipat, Haryana, India |
Peers are the five companies nearest above and the five nearest below Cureplus Pharma by revenue in the Ecommerce and Internet industry (Healthcare Products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Cureplus Pharma Private Limited
Cureplus Pharma Private Limited is audited by S B SAMANTA & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S B SAMANTA & CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Cureplus Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Cureplus Pharma Private Limited
Open charges
₹55 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Nov 2021 | State Bank of India | ₹55 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Cureplus Pharma Private Limited
Cureplus Pharma Private Limited has a workforce of 0 employees as of Apr 07, 2024.
Active EPFO establishments
1
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Cureplus Pharma Private Limited
Cureplus Pharma Private Limited has 12 board changes on record since 2020: 7 appointments and 5 cessations. The latest: Kumar Jena ceased to be Director on 11 Nov 2025.
Ceased
Kumar Jena ceased to be Director.
Appointed
Manish Chandra Ram Maurya was appointed as Director.
AGM
Cureplus Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Cureplus Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Cuttack.
Ceased
Aswini Kumar Padhy ceased to be Additional Director.
Ceased
Padmalaya Pradhan ceased to be Additional Director.
Ceased
Tanu Priya ceased to be Director.
Appointed
Kumar Jena was appointed as Director.
Appointed
Manishankar Panda was appointed as Director.
Charges
A charge with State Bank Of India amounted to Rs. 55.00 Lakh with Charge ID 100508358 was registered on 15 Nov 2021.
Appointed
Aswini Kumar Padhy was appointed as Additional Director.
Ceased
Subhrashree Jena ceased to be Additional Director.
4 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Cureplus Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Cureplus Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Cureplus Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Cureplus Pharma Private Limited
Cureplus Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AAJCC1955A1Z9 | Odisha | Active | 23 Dec 2020 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Cureplus Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cureplus Pharma Private Limited
Cureplus Pharma is an active private limited company based in Bhubaneswar, Odisha, India. The company works in online healthcare product retail, within the e-commerce industry. It was incorporated on 23 December 2020 (6+ years old) and is registered under CIN U51397OR2020PTC035178.
Cureplus Pharma reported revenue of ₹91.2 Lakh for FY 2023 (up 849% YoY).
Cureplus Pharma has 2 current directors:
- Manishankar Panda - Director
- Manish Chandra Ram Maurya - Director
Cureplus Pharma reported a net profit of ₹57,877 (net margin 0.6%) and EBITDA of ₹9.19 Lakh (EBITDA margin 10.1%) for FY 2023, as per its filed financial statements.
The GSTIN of Cureplus Pharma is 21AAJCC1955A1Z9, registered in Odisha.
The CIN (Corporate Identification Number) of Cureplus Pharma is U51397OR2020PTC035178. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cureplus Pharma was incorporated on 23 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Cureplus Pharma by revenue are Senera Essentials Private Limited, Ygeiax Sciences Private Limited, Tanmatra Ventures Private Limited, Duta Formulations Private Limited, Vedsun Natural Herbs Private Limited and 5 more, all in the Ecommerce and Internet industry (Healthcare Products).
Kumar Jena ceased to be Director on 11 Nov 2025. Manish Chandra Ram Maurya was appointed as Director on 11 Nov 2025. Aswini Kumar Padhy ceased to be Additional Director on 17 Feb 2023. Cureplus Pharma has 12 board changes on record in total.
Yes, Cureplus Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Cureplus Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-OD-19-0009200).